Andreas is a Principal Scientist at Genovis where he works on new workflows for characterization of biotherapeutics as well as the development of novel SmartEnzymes. He received his PhD from ETH Zurich in Switzerland in 2014 and has since then worked in different roles in academia and industry on using mass spectrometry-based approaches to study antibodies, their glycosylation and new enzymatic tools to analyze and modify them.